nattokinase NSK-SD
Selected indexed studies
- Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial. (Integr Blood Press Control, 2016) [PMID:27785095]
- A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles. (Sci Rep, 2015) [PMID:26109079]
- A pilot study on the serum pharmacokinetics of nattokinase in humans following a single, oral, daily dose. (Altern Ther Health Med, 2013) [PMID:23709455]
_Worker-drafted node — pending editorial review._
Connections
nattokinase NSK-SD protects against
nattokinase NSK-SD helps
Sources
- Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial. (2016) pubmed
- A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles. (2015) pubmed
- A pilot study on the serum pharmacokinetics of nattokinase in humans following a single, oral, daily dose. (2013) pubmed
- Toxicological assessment of nattokinase derived from Bacillus subtilis var. natto. (2016) pubmed